<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>§ 306-7 Schedule II. | Menominee Indian Tribe of Wisconsin Law Library</title>
    <link rel="shortcut icon" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/nsn/menominee/legislature/code/II/306/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/nsn/menominee/legislature/code/II/306/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/nsn/menominee/legislature/code" data-document="href"/>
    <meta itemprop="order" content="|II|306|1|II|306-7|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content="306-7"/>
    <meta itemprop="ref-doc" content="Code of the Menominee Indian Tribe" data-document=""/>
    <meta itemprop="ref-path" content="II|§306-7" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/nsn/menominee/legislature/code/II/306-7"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="§ 306-7 Schedule II. | Menominee Indian Tribe of Wisconsin Law Library"/>
    <meta property="og:image" content="/us/nsn/menominee/legislature/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#071346"/>
    <meta name="apple-mobile-web-app-title" content="Menominee Indian Tribe of Wisconsin Law Library"/>
    <meta name="theme-color" content="#071346"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/safari-pinned-tab.svg" color="#071346"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/nsn/menominee/legislature/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/nsn/menominee/legislature/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/fonts/ananda/ananda.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/fonts/roboto-condensed/roboto-condensed.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/nsn/menominee/legislature/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/nsn/menominee/legislature/code/II/306/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/nsn/menominee/legislature/code/II/306/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__menominee-nsn">
      <header id="section__header" class="ns__document__menominee-nsn">
        <div id="section__header__inner" class="ns__document__menominee-nsn">
          <div id="area__logo" class="ns__document__menominee-nsn">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/nsn/menominee/legislature/_document/v2/images/logo/logo.png" srcset="/us/nsn/menominee/legislature/_document/v2/images/logo/logo.png 1x, /us/nsn/menominee/legislature/_document/v2/images/logo/logo@2x.png 2x, /us/nsn/menominee/legislature/_document/v2/images/logo/logo@3x.png 3x" alt="Law Library of the Menominee Indian Tribe logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__menominee-nsn">
            <span class="h__library-title">Menominee Indian Tribe of Wisconsin Law Library</span>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__menominee-nsn">
        <div id="section__content__inner" class="ns__document__menominee-nsn">
          <section id="area__breadcrumbs" class="ns__document__menominee-nsn" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Menominee Indian Tribe of Wisconsin Law Library">Menominee Indian Tribe of Wisconsin Law Library</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/nsn/menominee/legislature/code" title="Code of the Menominee Indian Tribe">Code of the Menominee Indian Tribe</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II" title="Part II General Legislation">Part II General Legislation</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306" title="Chapter 306 DRUGS AND DRUG PARAPHERNALIA">Chapter 306 DRUGS AND DRUG PARAPHERNALIA</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306/1" title="Part 1 Controlled Substances">Part 1 Controlled Substances</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1|II" data-search-heading="">
                  <a href="/us/nsn/menominee/legislature/code/II/306/1/II" title="Article II Provisions for Scheduling; Schedules I, II, III, IV and V">Article II Provisions for Scheduling; Schedules I, II, III, IV and V</a>
                </li>
                <li data-search-path="library|Code of the Menominee Indian Tribe|II|306|1|II|306-7" data-search-heading="">
                  <span title="§ 306-7 Schedule II.">§ 306-7 Schedule II.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__menominee-nsn">
            <div class="h__document-title">Code of the Menominee Indian Tribe</div>
            <article class="content" role="document" data-ref-path="II|§306-7">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/nsn/menominee/legislature/code/II/306-7">§ 306-7 Schedule II.</h1>
                <p>Unless specifically excepted by tribal regulation or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, are listed in Schedule II:</p>
                <p class="text-indent-1 "><span class="level-num" id="A.">A.</span> Substances, plant origin or chemical synthesis. Unless specifically excepted or unless listed in another schedule, any of the following substances, whether produced directly or indirectly by extraction from substances of plant origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(1)">(1)</span> Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, isomers, and salts of isomers, but including the following:</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(a)">(a)</span> Codeine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(b)">(b)</span> Dihydroetorphine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(c)">(c)</span> Ethylmorphine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(d)">(d)</span> Etorphine hydrochloride.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(e)">(e)</span> Granulated opium.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(f)">(f)</span> Hydrocodone.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(g)">(g)</span> Hydromorphone.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(h)">(h)</span> Metopon.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(i)">(i)</span> Morphine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(j)">(j)</span> Opium extracts.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(k)">(k)</span> Opium fluid.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(l)">(l)</span> Oripavine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(m)">(m)</span> Oxycodone.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(n)">(n)</span> Oxymorphone.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(o)">(o)</span> Powdered opium.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(p)">(p)</span> Raw opium.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(q)">(q)</span> Thebaine.</p>
                <p class="text-indent-3 "><span class="level-num" id="A.(1)(r)">(r)</span> Tincture of opium.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(2)">(2)</span> Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in this section, except that these substances shall not include the isoquinoline alkaloids of opium.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(3)">(3)</span> Opium poppy and poppy straw.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(4)">(4)</span> Coca leaves and any salt, compound, derivative or preparation of coca leaves (including cocaine and ecgonine and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine.</p>
                <p class="text-indent-2 "><span class="level-num" id="A.(5)">(5)</span> Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).</p>
                <p class="text-indent-1 "><span class="level-num" id="B.">B.</span> Opiates. Unless specifically excepted or unless in another schedule, any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(1)">(1)</span> Alfentanil.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(2)">(2)</span> Alphaprodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(3)">(3)</span> Anileridine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(4)">(4)</span> Bezitramide.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(5)">(5)</span> Bulk dextropropoxyphene (nondosage forms).</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(6)">(6)</span> Carfentanil.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(7)">(7)</span> Dihydrocodeine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(8)">(8)</span> Diphenoxylate.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(9)">(9)</span> Fentanyl.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(10)">(10)</span> Isomethadone.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(11)">(11)</span> Levo-alphacetylmethadol (some other names: levo-alpha-acetylmethadol, levomethadyl acetate, LAAM).</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(12)">(12)</span> Levomethorphan.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(13)">(13)</span> Levorphanol.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(14)">(14)</span> Metazocine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(15)">(15)</span> Methadone.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(16)">(16)</span> Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(17)">(17)</span> Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(18)">(18)</span> Pethidine (meperidine).</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(19)">(19)</span> Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(20)">(20)</span> Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(21)">(21)</span> Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(22)">(22)</span> Phenazocine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(23)">(23)</span> Piminodine.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(24)">(24)</span> Racemethorphan.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(25)">(25)</span> Racemorphan.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(26)">(26)</span> Remifentanil.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(27)">(27)</span> Sufentanil.</p>
                <p class="text-indent-2 "><span class="level-num" id="B.(28)">(28)</span> Tapentadol.</p>
                <p class="text-indent-1 "><span class="level-num" id="C.">C.</span> Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(1)">(1)</span> Amphetamine, its salts, optical isomers, and salts of its optical isomers.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(2)">(2)</span> Methamphetamine, its salts, isomers, and salts of its isomers.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(3)">(3)</span> Phenmetrazine and its salts.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(4)">(4)</span> Methylphenidate.</p>
                <p class="text-indent-2 "><span class="level-num" id="C.(5)">(5)</span> Lisdexamfetamine, its salts, isomers, and salts of its isomers.</p>
                <p class="text-indent-1 "><span class="level-num" id="D.">D.</span> Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(1)">(1)</span> Amobarbital.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(2)">(2)</span> Glutethimide.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(3)">(3)</span> Pentobarbital.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(4)">(4)</span> Phencyclidine.</p>
                <p class="text-indent-2 "><span class="level-num" id="D.(5)">(5)</span> Secobarbital.</p>
                <p class="text-indent-1 "><span class="level-num" id="E.">E.</span> Hallucinogenic substances.</p>
                <p class="text-indent-2 "><span class="level-num" id="E.(1)">(1)</span> Nabilone [another name for nabilone: (+/-)-trans-3-(1,1-dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one].</p>
                <p class="text-indent-2 "><span class="level-num" id="E.(2)">(2)</span> (Reserved)</p>
                <p class="text-indent-1 "><span class="level-num" id="F.">F.</span> Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(1)">(1)</span> Immediate precursor to amphetamine and methamphetamine:</p>
                <p class="text-indent-3 "><span class="level-num" id="F.(1)(a)">(a)</span> Phenylacetone (some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone).</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(2)">(2)</span> Immediate precursors to phencyclidine (PCP):</p>
                <p class="text-indent-3 "><span class="level-num" id="F.(2)(a)">(a)</span> 1-phenylcyclohexylamine.</p>
                <p class="text-indent-3 "><span class="level-num" id="F.(2)(b)">(b)</span> 1-piperidinocyclohexanecarbonitrile (PCC).</p>
                <p class="text-indent-2 "><span class="level-num" id="F.(3)">(3)</span> Immediate precursor to fentanyl:</p>
                <p class="text-indent-3 "><span class="level-num" id="F.(3)(a)">(a)</span> 4-anilino-N-phenethyl-4-piperidine (ANPP).</p>
                <p class="text-indent-3 "><span class="level-num" id="F.(3)(b)">(b)</span> (Reserved)</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__menominee-nsn" aria-label="Previous and next article links">
            <section>
              <a href="/us/nsn/menominee/legislature/code/II/306-6" aria-label="§ 306-6 Schedule I.">
                <div class="h__ui">Previous</div>
                <span>§ 306-6 Schedule I.</span>
              </a>
            </section>
            <section>
              <a href="/us/nsn/menominee/legislature/code/II/306-8" aria-label="§ 306-8 Schedule III.">
                <div class="h__ui">Next</div>
                <span>§ 306-8 Schedule III.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__menominee-nsn">
        <div id="section__footer__inner" class="ns__document__menominee-nsn">
          <div id="area__footer__content" class="ns__document__menominee-nsn">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/menominee-nsn/law-html">HTML</a> or <a href="https://github.com/menominee-nsn/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
